Mette Bjerg Nielsen

Title: Mette Bjerg Nielsen: Innovator in Pharmaceutical Chemistry

Introduction

Mette Bjerg Nielsen is a prominent inventor based in Roskilde, Denmark. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on aminoalkoxy-functional chalcones. Her research focuses on developing novel compounds that have the potential to combat bacterial and parasitic infections.

Latest Patents

Mette holds a patent for her invention titled "Aminoalkoxy-functional chalcones." This invention provides novel alkoxyaminochalcone derivatives and analogues. The compounds, or compositions comprising them, are disclosed as pharmaceutically active agents, particularly effective against bacterial and parasitic infections. The invention also includes a method for detecting inhibitory effects against various pathogens, including bacteria, parasites, fungi, and helminths. The chalcones developed by Mette carry amino substituents and exhibit enhanced biological effects, combined with improved metabolic and physicochemical properties. This makes the compounds useful as drug substances, especially as antiparasitic, bacteriostatic, and bacteriocidal agents.

Career Highlights

Mette is currently associated with Lica Pharmaceuticals A/S, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of chalcone derivatives and their applications in medicine.

Collaborations

Mette collaborates with notable colleagues, including Simon Feldbæk Nielsen and Thomas Boesen. Their combined expertise contributes to the innovative research environment at Lica Pharmaceuticals A/S.

Conclusion

Mette Bjerg Nielsen is a trailblazer in the field of pharmaceutical chemistry, with her innovative patents paving the way for new treatments against infections. Her dedication to research and collaboration highlights the importance of innovation in healthcare.